HomeMy WebLinkAboutDEQ-CFW_00070820t
Mort, Sandra L
From: Behl, Betsy <Beh1.Betsy@epa.gov>
Sent: Friday, July 07, 2017 6:34 PM
To: Risen, Amy J; Audra Henry, Wheeler, John; Mitchell, Ken; Strong, Jamie; Henry, Tala;
Behrsing, Tracy, Benson, Amy; Aubee, Catherine; Kemker, Carol; Allenbach, Becky; Doa,
Maria; Mort, Sandra L; Shehee, Mina; Dittman, Elizabeth; Holt, Kennedy; Langley, Rick;
Brower, Connie; Culpepper, Linda; Holloway, Tracey S; Donohue, Joyce
Cc: Tina Forrester, Susan Moore; Selene Chou; Trent LeCoultre; idz7@cdc.gov
Subject: RE: GenX Risk Assessment Knowledge Gaps
A few minor clarifications below (it was hard to know who was speaking on the phone)
From: Risen, Amy J [mailto:Amy.Risen@dhhs.nc.gov]
Sent: Friday, July 07, 2017 6:17 PM
To: Audra Henry <atel@cdc.gov>; Wheeler, John <Wheeler.John@epa.gov>; Mitchell, Ken <Mitchell.Ken@epa.gov>;
Behl, Betsy <Behl.Betsy@epa.gov>; Strong, Jamie <Strong.Jamie@epa.gov>; Henry, Tala <Henry.Tala@epa.gov>;
Behrsing, Tracy <behrsing.tracy@epa.gov>; Benson, Amy <Benson.Amy@epa.gov>; Aubee, Catherine
<Aubee.Catherine@epa.gov>; Kemker, Carol <Kemker.Carol@epa.gov>; Allenbach, Becky <Allenbach.Becky@epa.gov>;
Doa, Maria <Doa.Maria@epa.gov>; Mort, Sandra L <sandy.mort@ncdenr.gov>; Shehee, Mina
<mina.shehee@dhhs.nc.gov>; Elizabeth Dittman <Beth.Dittman@dhhs.nc.gov>; Holt, Kennedy
<Kennedy.Holt@dhhs.nc.gov>; Langley, Rick <rick.langley@dhhs.nc.gov>; connie.brower@ncdenr.gov; Culpepper, Linda
<1inda.culpepper@ncdenr.gov>; Holloway, Tracey S <Tracey. Holloway@ ncdenr.gov>; Donohue, Joyce
<Donohue.Joyce@epa.gov>
Cc: Tina Forrester <txf5@cdc.gov>; Susan Moore <sym8@cdc.gov>; Selene Chou <cjc3@cdc.gov>; Trent LeCoultre
<t117@cdc.gov>; idz7@cdc.gov
Subject: RE: GenX Risk Assessment Knowledge Gaps
Thank you to everyone for providing feedback on our risk assessment for GenX. I'm providing a summary below, which
includes points of contact to follow up with. Questions 1-4 were posed by DHHS before the call as main talking points.
Text in blue is a summary of the comments. NC DHHS makes every attempt to follow the approach used by the EPA
when doing risk assessments. Therefore, we have underlined blue text as take home messages that DHHS will be
applying to the GenX risk assessment for NC residents using drinking water originally referenced in Sun et al 2016.
DHHS intends to respond to the public with a new drinking water level and health guidance early in the week of July 101n
We are hopeful that you will be able to provide feedback on cancer and fish consumption ASAP; please see number 5
below for details. I am also interested in data we discussed on interspecies kinetics differences.
Thanks again!
Amy
1) Animal toxicity studies and the point of departure (POD): Sufficient data was available to lower the POD NOAEL
to 0.1 mg/kg/day (subchronic toxicity test OECD 407 with mice). An uncertainty factor of 10 will be applied for
subchronic to chronic extrapolation
a. We have consensus that the POD of 0.1 me/ke/day will also be used by the EPA Risk Assessment
Division (RAD) for risk assessment of GenX.
b. Joyce Donohue, Tracy Behrsing & Amy Benson requested that toxicological effects and endpoint
descriptions be strengthened so we can be more specific about the effects associated with NOAELs and
PODS that are referenced during the risk assessment.
DEQ-CFW 00070820
c. It was noted that PODs on the ECHA dossier are selected and reported by chemical manufacturer rather
than the ECHA.
2) Routes of exposure and the relative source contribution (RSC): People may be exposed to GenX through routes
other than drinking water. The typical value used for RSC in risk assessment of organic chemicals is 0.2, and this
is the value used by the EPA for their evaluation of PFOA and PFOS drinking water health advisories. We request
guidance from the EPA and ATSDR on the use of an RSC of 0.2.
a. EPA RAD has not evaluated RSC for drinking water exposures to GenX because drinking water was not
previously thought to be a route of exposure to this chemical.
b. EPA OST RAD did use 20% RSC for PFOA and PFOS due to ubiquitous presence in the environment and
uncertainty about amounts of these chemicals reaching people through the different exposure routes.
c. EPA OST RAD uses 100% RSC when looking at exposures to the infant age group.
d. DHHS intends to use 20% RSC based on the EPA decision tree for deriving water quality criteria (EPA-
822-13-00-004) and apply the exposure to children birth to <6years using exposure factors from the
new EPA RAGS supplement (OSWER Directive 9200.1-120).
3) Risk assessment method and interspecies uncertainty factor: The default value for interspecies variability of 10
is likely to underestimate the toxicity of GenX to humans. We present the EPA method used to extrapolate a
human equivalent dose (HED) for PFOA and PFOS in this document. Interspecies uncertainty modeling for PFOA
and PFOS yielded a calculated factor of 140 to 71OX for kinetics differences and an additional 3X was allocated
for other variability across species. The total uncertainty accounted for across species by EPA for PFOA and PFOS
was calculated by DHHS and the maximum was 2,100X. We also request guidance from the EPA and ATSDR on
an appropriate interspecies uncertainty factor for GenX.
a. DHHS understands that EPA RAID currently intends to use a UFTota1=100 for their risk assessment for
the consent order for GenX manufacturing (UF,ntraspecies=10 & UF,nterspecies=10).
b. EPA: While human PFOS & PFOA clearance rates are slower in humans than test animals, interspecies
kinetics variability is not expected to occur at the same magnitude for GenX. The supporting information
comes from a comparison of the clearance rates for branched vs linear PFOAs, in which branched
isomers are cleared faster; GenX is branched and so would be predicted to clear faster.
L DHHS requests references on comparison of branched vs linear PFOAs, renal transfer proteins
used, and any additional information helpful in reviewing the prediction of the interspecies
variability expected for GenX. Follow up discussions will go through Joyce Donohue, Catherine
Aubree, and Jaime Strong as points of contact.
c. Additional UFs were discussed, including the subchronic to chronic extrapolation. EPA RAD does not use
a UFsubchronic-chronic as part of its typical procedure. DHHS explained our goal to be protective of public
health over a lifetime of exposure. EPA explained that EPA IRIS procedure does focus more on lifetime
exposures and their risk assessment does add in a UFsubchronic-chronic of 10.
d. Questions were raised regarding EPA's current review of the GenX consent order and associated risk
assessment; now that a release to a water source is known, will the risk assessment include a public
drinking water level?
4) Drinking water concentration guidance for other PFECAs: The Sun et al 2016 publication identified not only
GenX, but also other perfluoroalkyl ether carboxylic acids (PFECAs) present in the Cape Fear River and local
drinking water in 2013 and 2014. Quantification of the concentrations of other PFECAs was not possible due to
the lack of analytical chemistry standards, however some PFECAs may have been present at concentrations 15
times higher than GenX. Presumed high concentrations are prompting questions about drinking water safety,
DEQ-CFW 00070821
however no toxicity data is available for these PFECAs. We request guidance from the EPA and ATSDR on a
health protective drinking water value that can be provided to residents of this community. Would it be
appropriate to use the PFOA + PFOS health advisory of 70 ng/L?
a. Maria Doa and Catherine Aubree will review the PFECAs chemical structures to see if general advice can
be given on how much we can read across health concerns from PFOA and PFOS. It is not within the
scope of their work on GenX to review PFECAs at this time and it is understood that guidance along
these lines may be limited. Amy Risen will provide the supplemental document for Sun et al to clarify
the PFECAs in question.
5) Additional questions raised in call
a. Fish Consumption:
i. DHHS: The public is asking about safety of fish consumption. Can the EPA make any
recommendations?
EPA: The EPA does not expect GenX to bioaccumulate. There is some data on concentrations in
fish from documents that are confidential, as well as some non -confidential data.
1. The DHHS spoke with Tala Henry after the call for clarification. She explained that the
BCF reported by Hoke et al 2016 is low enough as to not typically warrant additional fish
consumptions studies. EPA will follow up Monday with a statement with the appropriate
caveats for the unknowns of emerging chemicals and limited data.
b. Cancer Risk Assessment:
DHHS: The public is concerned about the risk of cancer from GenX. We have limited data, but
can the EPA suggest a way to convey the risk of cancer?
EPA: Joyce Donohue will review the raw data from OECD 453 to determine if the notes on the
rate of occurrence for liver necrosis are sufficient to calculate a risk. Amy Risen will provide the
raw data, which had been provided by Chemours. Amy also has raw data for OECD 407 GenX
testing for rats & mice, if needed by anyone in the group.
From: Risen, Amy J
Sent: Wednesday, July 05, 2017 7:38 PM
To: 'Audra Henry' <atel@cdc.gov>; 'John Wheeler' <Wheeler.John2EPA.gov>; 'mitchell.ken@epa.gov'
<mitchell.ken@epa.gov>; 'Behl.betsy@epa.gov' <Behl.betsy@epa.gov>; 'Strong.jamie@epa.gov'
<Strong.warn ie@epa.gov>; 'Henry.tala@epa.gov' <Henry.tala@epa.gov>; 'Behrsing.tracy@epa.gov'
<Behrsing.tracv@epa.govv>; 'Benson.amy@epa.gov' <Benson.amy@epa.gov>; 'Aubee.catherine@epa.gov'
<Aubee.Catherine@epa.gov>;'Kemker.carol@epa.gov' <Kemker.carol@epa.goov>;'Allenbach.becky@epa.gov'
<Allenbach.becky@epa.gov>; 'Doa, Maria' <Doa.Maria@epa.gov>; Mort, Sandra L <sandy.mort@ncdenr.gov>; Shehee,
Mina <mina.shehee@dhhs.nc.gov>; Dittman, Elizabeth <Beth.Dittman@dhhs.nc.gov>; Holt, Kennedy
<Kennedy.Holt dhhs.nc.gov>; Langley, Rick <rick.langley@dhhs.nc.gov>; Brower, Connie <connie.brower@ncdenr.gov>
Cc: 'Tina Forrester' <txf5@cdc.gov>; 'Susan Moore' <sym8@cdc.gov>; 'Selene Chou' <cic3@cdc.gov>; 'Trent LeCoultre'
<t117@cdc.gov>; 'Rachel Worley' <idz7@cdc.gov>
Subject: GenX Risk Assessment Knowledge Gaps
Hello everyone!
NC DHHS has been discussing GenX with both EPA and ATSDR and we really appreciate the help you've been giving us.
We'll be holding a conference call tomorrow to talk about the progress we've made on our GenX risk assessment, and
DEQ-CFW 00070822
talk about knowledge gaps. We'll be asking for rapid feedback within the next week to help inform our risk
communications with the public.
I've attached a document for you to review with requests for feedback bolded in purple.
Thanks so much and talk to you all tomorrow!
Amy Risen, PhD
Environmental Toxicologist
Division Public Health, Occupational and Environmental Epidemiology
North Carolina Department of Health and Human Services
(919) 707-5911 office
(919) 870-4807 fax
Amv.Risen0.dhhs.nc.gov
5505 Six Forks Road
1912 Mail Service Center
Raleigh, NC 27699-1912
A.
tro.d� rarofiva
Email correspondence to and from this address is subject to the North Carolina Public Records Law and may be disclosed to third parties by an
authorized State official. Unauthorized disclosure of juvenile, health, legally privileged, or otherwise confidential information, including confidential
information relating to an ongoing State procurement effort, is prohibited by law. If you have received this email in error, please notify the sender
immediately and delete all records of this email.
4
DEQ-CFW 00070823